Summary

US Interventional Neurology Devices Market is valued approximately at USD 687.45 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.25% over the forecast period 2024-2032. Interventional neurology devices are specialized instruments utilized by neurologists and neurosurgeons for minimally invasive procedures that target the brain, spinal cord, and associated blood vessels. These devices encompass a range of tools such as neurovascular stents, embolic coils, catheters, embolization devices, neurothrombectomy devices, intracranial stents, neuroendovascular clipping devices, and flow diverters. They play a pivotal role in treating conditions like aneurysms, stroke, intracranial stenosis, and other vascular abnormalities. Compared to traditional open surgeries, these devices offer advantages such as shorter recovery times and enhanced patient outcomes. The growing focus on technological innovation and advancement in neurovascular interventions is a major growth trend in the US Interventional Neurology Devices Market. This trend encompasses the development and implementation of advanced medical devices, such as neurovascular stents, flow diverters, and neurothrombectomy systems, with the goal of enhancing patient outcomes and lowering treatment-related problems.

Factors such as the rising prevalence of neurodegenerative conditions like Alzheimer's and Parkinson's, ongoing product innovations, and a growing preference for less invasive treatment options are primarily attributing to the demand of the interventional neurology devices at a substantial rate. Also, the increasing incidence of neurological disorders in the region is acting as a catalyzing factor for the Interventional Neurology Devices Market. As per NIH Trauma varying from a minor hit to the head to a deep wound to the brain cause traumatic brain injury (TBI). In the United States, an estimated 1.7 million individuals experience traumatic brain injuries annually, with higher prevalence witnessed among adolescents aged 15 to 19 and adults aged 65 and above. Furthermore, the healthcare system in the US emphasizes improving patient outcomes and quality of life. Interventional neurology devices often offer faster and more effective treatment for neurological conditions, leading to better patient outcomes and lower long-term healthcare costs. However, high cost of devices and stringent regulatory scenario is likely to stifle market growth between 2022 and 2032.


Major market player included in this report are:
Abbott Laboratories
Boston Scientific Corporation
Johnson & Johnson
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10



The detailed segments and sub-segment of the market are explained below:

By Product Type
Cerebral Balloon Angioplasty and Stenting Systems
Neurothrombectomy Devices
Aneurysm Coiling and Embolization Devices
Micro-catheters
Guidewires

By Application
Artery Stenosis
Ischemic Strokes
Brain Aneurysm
Vein Stenosis
Others


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Interventional Neurology Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Interventional Neurology Devices Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Product Type
2.2.2. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Interventional Neurology Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Interventional Neurology Devices Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Interventional Neurology Devices Market Size & Forecasts by Product Type 2022-2032
5.1. Cerebral Balloon Angioplasty and Stenting Systems
5.2. Neurothrombectomy Devices
5.3. Aneurysm Coiling and Embolization Devices
5.4. Micro-catheters
5.5. Guidewires
Chapter 6. US Interventional Neurology Devices Market Size & Forecasts by Application 2022-2032
6.1. Artery Stenosis
6.2. Ischemic Strokes
6.3. Brain Aneurysm
6.4. Vein Stenosis
6.5. Others
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Abbott Laboratories
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Boston Scientific Corporation
7.3.3. Johnson & Johnson
7.3.4. Company 4
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes